· 个股论点
TLDR：如果没有稀释，仅因TA-ERT催化剂，股价可能暂时涨至$500。但这在稀释日如同玩俄罗斯轮盘赌。 我花更多时间研究了细节： $SPRB 的合理市值约为1.5亿-2亿美元（目前8500万）。原帖作者声称目标价$500，若公司不稀释则合理。 然而： 截至2025年6月30日，SPRB现金等价物仅1640万美元，鉴于现金余额低，通过增发新股进行稀释似乎不可避免。股价上涨源于低流通盘+利好消息（无16%这样的空头头寸，故非空头挤压）。 增发新股+稀释后（市值1.5亿-2亿美元可能使股价回归~$50-75），若计入稀释，我不认为能看到$500的目标价。 我们可能会因流通盘有限看到另一波100%+的上涨冲向$500（就像$BULL因低流通盘涨至600亿市值那样），但由于随机日期的稀释如同俄罗斯轮盘赌，我不建议长期持有。 无论如何，我喜欢玩俄罗斯轮盘赌。欢迎任何反驳观点。
TLDR: Might go up to $500 temporary strike if there's no dilution just because of TA-ERT catalyst. But it's playing Russian Roulette on dilution days. So had some more time to look into things: Fair value $SPRB market cap is = ~$150–200m. ($85M now). In OP's post they claimed $500 PT, which is fair if company doesn't dilute. However: SPRB has $16.4M in cash equivalents, June 30, 2025, dilution with new shares seems inevitable just because of low cahs balance. Price rise was due to low float + good news (there's no short interest like .16% so not a short squeeze) After issuing new shares + dilution (Market cap at $150m-$200m might normalize share price to ~$50-75), don't really see the $500 figure if dilution is included. We might see another 100%+ runup just because of limited float toward that $500 mark (like how $BULL ran to a $60B MC off low float), but I would be against holding it long term because of russian roulette dilution on a random day. Either way, I like playing Russian Roulette. Welcome any counterpoints